Skip to main content

Oncologists Accepting Blue Cross and Blue Shield of Massachusetts in Boston, MAPage 2

238 verified oncologists in Boston, Massachusetts accept Blue Cross and Blue Shield of Massachusetts. Profiles cover focus areas including Radiation Oncology, Breast Oncology, and Medical Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Massachusetts General Hospital.

Peter Orio

Peter Orio, D.O.

Chair of the Department of Radiation Oncology at Dana-Farber Cancer Institute. For the past ten years, he served as the Vice Chair of Network Operations fo

Oncology

Boston, MA20+ years
Radiation Oncology
Erica Mayer

Erica Mayer, MD MPH

Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School; Director, Breast Cancer Clinical Research, Dana-Farber Breast Oncology Program

Oncology

Boston, MA20+ years
Breast OncologyMedical Oncology
Jennifer Ligibel

Jennifer Ligibel, MD

Professor at Harvard Medical School and a Senior Physician in the Breast Oncology Center at the Dana-Farber Cancer Institute. Dr. Ligibel’s research focuses on; Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living and has built a comprehensive clinical Healthy Living Program for patient

Oncology

Boston, MA30+ years
Medical Oncology
Elizabeth Baldini

Elizabeth Baldini, MD , MPH

Professor of Radiation Oncology, Harvard Medical School; Director, Sarcoma Radiation Oncology

Oncology

Boston, MA30+ years
Thoracic Oncology
Heather Jacene

Heather Jacene, M.D.

Clinical Director, Nuclear Medicine/PET-CT

Oncology

Boston, MA20+ years
Radiation Oncology
Mark Preston

Mark Preston, M.D.

Associate Professor of Surgery, Harvard Medical School

Oncology

Boston, MA20+ years
Genitourinary Oncology
Ann Partridge

Ann Partridge, MD MPH

Chief Clinical Strategy Officer, Vice Chair of Medical Oncology, and founder and director of Young and Strong, the Program for Young Adults with Breast Can; Chair in Breast Cancer Research at Dana-Farber. She conducts clinical research focused on improving cancer care and outcomes with a particular focus on you

Oncology

Boston, MA30+ years
Medical Oncology
Elisabeth Battinelli

Elisabeth Battinelli, M.D.

Associate Professor of Medicine, Harvard Medical School; Chief Resident, Medicine

Oncology

Boston, MA20+ years
Jeremy Abramson

Jeremy Abramson, MD

Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma, Massachusetts General Hospital Cancer Center; Associate Professor of Medicine, Harvard Medical School

Oncology

Boston, MA20+ years
Hematology & OncologyMedical Oncology
Elizabeth Buchbinder

Elizabeth Buchbinder, M.D.

Assistant Professor of Medicine, Harvard Medical School

Oncology

Boston, MA20+ years
Melanoma & Cutaneous OncologyMedical Oncology
Jiping Wang

Jiping Wang, MD, PHD

Surgical Oncologist, Associate Professor of Surgery, Harvard Medical School

Oncology

Boston, MA30+ years
Surgical Oncology
Thomas Spitzer

Thomas Spitzer, MD

Professor of Medicine, Harvard Medical School; Director, Bone Marrow Transplant Program, Massachusetts General Hospital

Oncology

Boston, MA30+ years
Medical Oncology
Filipa Lynce

Filipa Lynce, M.D.

Assistant Professor of Medicine, Harvard Medical School; Associate Director, Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute

Oncology

Boston, MA20+ years
Breast OncologyMedical Oncology
Ann Silk

Ann Silk, M.D.

Director of the Merkel Cell Carcinoma Center of Excellence; Assistant Professor of Medicine, Harvard Medical School

Oncology

Boston, MA15+ years
Medical Oncology
Neil Horowitz

Neil Horowitz, MD

Surgical Director, Gynecologic Oncology; Director, Clinical Research in Gynecologic Oncology; Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

Oncology

Boston, MA30+ years
George Demetri

George Demetri, MD

Professor of Medicine, Harvard Medical School; Director, Sarcoma Center, Dana-Farber Cancer Institute; Senior Vice President for Experimental Therapeutics, Dana-Farber Cancer Institute; Co-Director, Ludwig Center at Dana-Farber/Harvard

Oncology

Boston, MA30+ years
SarcomaMedical Oncology
David Kuter

David Kuter, MD DPHIL

Director of Clinical Hematology at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School

Oncology

Boston, MA30+ years
Hematology & OncologyMedical Oncology
David Kozono

David Kozono, M.D., PH.D.

Assistant Professor of Radiation Oncology, Harvard Medical School; Director, Thoracic Radiation Oncology

Oncology

Boston, MA20+ years
Thoracic Oncology
Leif Ellisen

Leif Ellisen, MD PHD

Professor of Medicine, Harvard Medical School; Program Director, Breast Medical Oncology, Mass General Cancer Center

Oncology

Boston, MA30+ years
Breast OncologyMedical Oncology
Pamela Dipiro

Pamela Dipiro, M.D.

Associate Professor of Radiology, Harvard Medical School

Oncology

Boston, MA30+ years
Radiation Oncology

Frequently Asked Questions

How do I know these oncologists accept Blue Cross and Blue Shield of Massachusetts?
Each profile on this page lists Blue Cross and Blue Shield of Massachusetts among its accepted health plans. Plan participation can change — confirm directly with the practice before your visit.
What Blue Cross and Blue Shield of Massachusetts plans do these oncologists accept?
Plan-level detail (PPO, HMO, EPO, Medicare Advantage, etc.) varies by specialists. Open a specific provider profile to see the exact Blue Cross and Blue Shield of Massachusetts plans they've published as accepted.
What should I look for when picking a oncologist that takes Blue Cross and Blue Shield of Massachusetts?
Start with clinical fit. Profiles on this page mention focus areas including Radiation Oncology, Breast Oncology, and Medical Oncology. Then verify the specific Blue Cross and Blue Shield of Massachusetts plan you carry, compare credentials and affiliations, and check whether the profile mentions accepting new patients.
Are these oncologists accepting new patients?
Profile detail on availability varies. Open a specific profile to see what each provider has published about new-patient access and typical wait times.